PHARMA SIGNALOPEN RESEARCH PLATFORM →
PHARMASIGNAL DIRECTORY

Active Phase 2 and Phase 3 Clinical Trials

Selected active clinical trials linked to PharmaSignal company profiles and primary ClinicalTrials.gov records.

NCT03567889

Phase 3 · Recruiting · Melanoma Stage IIIB

NCT03969329

Phase 3 · Recruiting · Secondary Hyperparathyroidism

NCT04316364

Phase 3 · Recruiting · Non-Small-Cell Lung Cancer

NCT04817618

Phase 3 · Recruiting · C3G

NCT04892173

Phase 3 · Recruiting · Carcinoma, Squamous Cell

NCT04921527

Phase 3 · Recruiting · Ovarian Cancer

NCT04951635

Phase 3 · Recruiting · Non-small Cell Lung Cancer

NCT04965675

Phase 3 · Recruiting · Chronic Migraine in Children

NCT05020236

Phase 3 · Recruiting · Multiple Myeloma

NCT05077904

Phase 3 · Recruiting · Stereotypical Prolonged Seizures

NCT05261139

Phase 3 · Recruiting · COVID-19

NCT05302284

Phase 3 · Recruiting · Urothelial Carcinoma

NCT05319353

Phase 3 · Recruiting · Cytomegalovirus (CMV)

NCT05489289

Phase 3 · Recruiting · Hepatocellular Carcinoma

NCT05511363

Phase 3 · Recruiting · Psychosis Associated With Alzheimer's Disease

NCT05633654

Phase 3 · Recruiting · Triple Negative Breast Cancer

NCT05646862

Phase 3 · Recruiting · Breast Cancer

NCT05751512

Phase 3 · Recruiting · Squamous Cell Carcinoma of the Head and Neck

NCT05970172

Phase 3 · Recruiting · Chronic Kidney Disease

NCT06041776

Phase 3 · Recruiting · Non-Small Cell Lung Cancer

NCT06079983

Phase 3 · Recruiting · Breast Cancer

NCT06100744

Phase 3 · Recruiting · Juvenile Psoriatic Arthritis

NCT06104566

Phase 3 · Recruiting · CLL/SLL

NCT06174987

Phase 3 · Recruiting · Advanced Cancer

NCT06196736

Phase 3 · Recruiting · Advanced Urothelial Carcinoma

NCT06279364

Phase 3 · Recruiting · Triple Negative Breast Cancer

NCT06296706

Phase 3 · Recruiting · Gastric Cancer

NCT06313086

Phase 3 · Recruiting · HER2-positive Breast Cancer

NCT06340568

Phase 3 · Recruiting · Endometrial Cancer

NCT06371157

Phase 3 · Recruiting · Hepatocellular Carcinoma

NCT06389136

Phase 3 · Recruiting · Atopic Dermatitis

NCT06417814

Phase 3 · Recruiting · Metastatic Non-small Cell Lung Cancer

NCT06430437

Phase 3 · Recruiting · Non-Small Cell Lung Cancer With HER2- Mutations

NCT06452277

Phase 3 · Recruiting · Advanced Non-small Cell Lung Cancer, HER2 Mutation

NCT06496048

Phase 3 · Recruiting · Relapsed Small Cell Lung Cancer

NCT06532006

Phase 3 · Recruiting · Gastroesophageal-junction Cancer

NCT06579573

Phase 3 · Recruiting · Epilepsy, Generalized

NCT06655883

Phase 3 · Recruiting · Insomnia

NCT06660992

Phase 3 · Recruiting · Non-cystic Fibrosis Bronchiectasis

NCT06664619

Phase 3 · Recruiting · Asthma

NCT06672549

Phase 3 · Recruiting · Obesity

NCT06685978

Phase 3 · Recruiting · Hyperplasia of Mammary Glands

NCT06697886

Phase 3 · Recruiting · Common Cold

NCT06716203

Phase 3 · Recruiting · Type 2 Diabetes Mellitus (T2DM)

NCT06716216

Phase 3 · Recruiting · Type 2 Diabetes Mellitus (T2DM)

NCT06716814

Phase 3 · Recruiting · Haemophilia A (Moderate or Severe)

NCT06767514

Phase 3 · Recruiting · Non-Small Cell Lung Cancer

NCT06780410

Phase 3 · Recruiting · Primary Hyperlipidemia

NCT06822790

Phase 3 · Recruiting · Hypertriglyceridemia

NCT06842199

Phase 3 · Recruiting · Plaque Psoriasis Patients

NCT06881784

Phase 3 · Recruiting · NSCLC (Non-small Cell Lung Cancer)

NCT06894212

Phase 3 · Recruiting · Schizophrenia

NCT06914609

Phase 3 · Recruiting · Angelman Syndrome

NCT06926491

Phase 3 · Recruiting · Achondroplasia

NCT06935357

Phase 3 · Recruiting · Immunoglobulin A Nephropathy (IgAN)

NCT07015905

Phase 3 · Recruiting · Venous Thromboembolism (VTE)

NCT07036172

Phase 3 · Recruiting · Obesity Control

NCT07103148

Phase 3 · Recruiting · Yellow Fever Immunization

NCT07124221

Phase 3 · Recruiting · Hyperprolactinemia

NCT07189455

Phase 3 · Recruiting · Small-cell Lung Cancer

NCT07218146

Phase 3 · Recruiting · Small-cell Lung Cancer

NCT07223203

Phase 3 · Recruiting · Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy

NCT07234162

Phase 3 · Recruiting · Peripheral T-cell Lymphoma

NCT07279194

Phase 3 · Recruiting · Obesity & Overweight

NCT07361003

Phase 3 · Recruiting · Refractory Metastatic Colorectal Cancer

NCT07362459

Phase 3 · Recruiting · Non-Small Cell Lung Carcinoma (NSCLC)

NCT07435428

Phase 3 · Recruiting · Moderate to Severe Glabellar Lines

NCT07469800

Phase 3 · Recruiting · Overweight

NCT07515079

Phase 3 · Recruiting · Diabetic Macular Edema (DME)

NCT07527078

Phase 3 · Recruiting · Type 2 Diabetes (T2DM)

NCT07617597

Phase 3 · Recruiting · Alopecia Areata

NCT07625280

Phase 3 · Recruiting · Narcolepsy

NCT07745504

Phase 3 · Recruiting · Overweight

NCT07746544

Phase 3 · Recruiting · COVID-19

NCT02716246

Phase 2 · Recruiting · MPS IIIA

NCT03736889

Phase 2 · Recruiting · MSI-H/dMMR Solid Tumors

NCT05744687

Phase 2 · Recruiting · Locally Advanced or Metastatic Breast Cancer

NCT06111274

Phase 2 · Recruiting · Advanced Pancreatic Cancer

NCT06737081

Phase 2 · Recruiting · Anemia

NCT06821945

Phase 2 · Recruiting · Schizophrenia

NCT06953089

Phase 2 · Recruiting · Solid Tumors

NCT06956196

Phase 3 · Not Yet Recruiting · Atopic Dermatitis

NCT06983028

Phase 2 · Recruiting · pMN

NCT07013279

Phase 3 · Not Yet Recruiting · Glabellar Lines

NCT07239336

Phase 2 · Recruiting · Celiac Disease

NCT07493265

Phase 2 · Recruiting · Narcolepsy

NCT07762833

Phase 3 · Not Yet Recruiting · Atopic Dermatitis

NCT04647253

Phase 3 · Active Not Recruiting · In-Stent Restenosis

NCT06226714

Phase 3 · Active Not Recruiting · Meningococcal Meningitis

NCT06246513

Phase 3 · Active Not Recruiting · Limb-girdle Muscular Dystrophy